Nutritional antioxidants, red cell membrane fluidity and blood viscosity in Type 1 (insulin dependent) diabetes mellitus

Diabetic Medicine

Volumn 13, Issue 12, 1996, Pages 1044-1050

  Osterode, W ^a   Holler, C ^b   Ulberth, F ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b GENERAL HOSPITAL LINZ   (Austria)

^c UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Blood viscosity; Glutathione peroxidase; Selenium; Type 1 diabetes mellitus; Vitamin A; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; GLUTATHIONE PEROXIDASE; RETINOL; SELENIUM;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD VISCOSITY; CELL MEMBRANE FLUIDITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE;

EID: 0029908141     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-9136(199612)13:12<1044::aid-dia273>3.0.co;2-#     Document Type: Article

References (41)

1. Watala C. Altered structural and dynamic properties of blood cell membranes in diabetes mellitus. Diabetic Med 1993; 10: 13-20.
2. Kamada T, Otsuji STI. Lower levels of erythrocyte membrane fluidity in diabetic patients. A spin label study. Diabetes 1983; 32: 585-591.
3. Otsuji S, Baba Y, Kamada T. Erythrocyte membrane microviscosity in diabetes. Horm Metab Res 1981; 11 (suppl): 97-102.
4. Bryszewska M, Watala C, Torzecka W. Changes in fluidity and composition of erythrocyte membranes and in composition of plasma lipids in type I diabetes. Br J Hematol 1986; 62: 111-116.
5. Hill MA, Court JMTI. Erythrocyte membrane fluidity in type I diabetes mellitus. Pathology 1983; 15: 449-451.
6. Watala C, Winocour PD. The relationship of chemical modification of membrane proteins and plasma lipoproteins to reduced membrane fluidity of erythrocyte from diabetic subjects. Eur J Clin Chem Clin Biochem 1992; 30: 513-519.
7. Mazzanti L, Rabini RA, Testa I, Bertoli E. Modifications induced by diabetes on the physiochemical and functional properties of erythrocyte plasma membrane. Eur J Clin Invest 1989; 19: 84-89.
8. McMillan DE. Disturbance of serum viscosity in diabetes mellitus. J Clin Invest 1974; 53: 1071-1079.
9. Lowe GDO, Lowe JM, Drummond MM, Reith S, Blech JJF, Kesson M, et al. Blood viscosity in young male diabetics with and without retinopathy. Diabetologia 1980; 18: 359-363.
10. Lowe GDO, Ghafour IM, Blech JJF, Forbes CD, Foulds WS, MacCuish AC. Increased blood viscosity in diabetic proliferative retinopathy. Diabetes Res 1986; 3: 67-70.
11. Bertram B, Wolf S, Schulte K, Pesch TW, Jung F, Kiesewetter H, Reim M. Blood rheology and retinopathy in adult type I diabetes mellitus. Clinical Hemorheol 1992; 12: 437-448.
12. Barnes AJ, Oughton J, Kohner EM. Blood rheology and the progression of diabetic retinopathy: a prospective study. Clin Hemorheol 1987; 7: 460-467.
13. Tong P, Thomas T, Berrish T, Humphriss D, Barriocanal, Stewart M, et al. Cell membrane dynamics and insulin resistance in non-insulin dependent diabetes mellitus. Lancet 1995; 345: 357-358.
14. Clemens RC, Waller HD. Lipid peroxidation in erythrocytes. Chem Phys Lipids 1987; 45: 251-268.
15. Wagner GM, Lubin BH, Chiu DT-Y. Oxidative damage to red blood cells. In: Chow CD, ed. Cellular Defense Mechanisms, vol. 1. Boca Raton, Florida: CRC Press, Inc., 1988: 185-195.
16. Giugliano D, Ceriello A, Paolisso G. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 1994; 44: 363-368.
17. Baynes JW. Role of oxidative stress in development of oxidative complications in diabetes. Diabetes 1991; 40: 405-412.
18. Costagliola C, Iuliano G, Menzione M, Nesti A, Simonelli F, Rinaldi E. Systemic human diseases as oxidative risk factor in cataractogenesis: I. Diabetes. Ophthalmic Res 1988; 20: 308-316.
19. Paolisso G, D'Amore A, Di Maro G, Galzerano D, Tesauro P, Varricchio M, D'Onofrio F. Evidence for a relationship between free radicals and insulin action in the elderly. Metabolism 1993; 62: 659-663.
20. Matkovics B, Szl V, Szabo L, Witas H. The effect of diabetes on the activities of the peroxide metabolism enzymes. Horm Metabol Res 1982; 14: 77-79.
21. Grankvist K, Marklund SL, Täljdal IB. CuZn-superoxide dismutase, catalase is a prophylactic against alloxan diabetes. Nature 1981; 294: 158-160.
22. Hägglöf B, Marklund SL, Holmgren G. CuZn superoxide dismutase, Mn superoxide dismutase, catalase and glutathione peroxidase in lymphocytes and erythrocytes in insulin-dependent children. Acta Endocrinol 1983; 102: 235-239.
23. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-795.
24. Hansson L, Petterson J, Eriksson L, Olin A. Atomic absorption spectrometric determination of selenium in human blood components. Clin Chem 1989; 35: 537-542.
25. Paglia DE, Valentine WN. Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
26. Von Kampen EJ, Zijlstra WG. Standardization of hemoglobinometry. II. The hemoglobincyanide method. Clin Chem Acta 1961; 6: 538-544.
27. Bieri JG, Tolliver TJ, Citignani GL. Simultaneous determination of α-tocopherol and retinol in plasma or red blood cells by high performance liquid chromatography. Am J Clin Nutr 1979; 32: 2143-2149.
28. Schneditz D, Ribitsch V, Kenner T. Rheological discrimination between native, rigid and aggregated red blood cells in oscillatory flow. Biorheol 1985; 22: 209-219.
29. Ezaki O. The insulin-like effect of selenat in rat adipocytes. J Biol Chem 1990; 15: 1124-1128.
30. McNeill JH, Delgatty HL, Battell ML. Insulinlike effects of sodium selenate in streptozocin-induced diabetic rats. Diabetes 1991; 40: 1675-1678.
31. Juhan-Vague I, Rahmani-Jourdheuil D, Mishal Z, Roul C, Mourayre Y, Aillaud MF, Vague P. Correction by insulin added in vitro of abnormal membrane fluidity of the erythrocytes from type I (insulin-dependent) diabetic patients. Diabetologia 1986; 29: 417-420.
32. Uzel N, Sivas A, Uysal M, Öz H. Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus. Horm Metabol Res 1987; 19: 89-90.
33. Sklodowska M, Gromadzinska J, Wasowicz W. Lipid peroxide concentration, selenium level, and glutathione peroxidase activity in blood of type II (non-insulin-dependent) diabetic elderly people. J Clin Biochem Nutr 1989; 7: 35-41.
34. Jung F, Koscielny J, Mrowietz C, Wolf S, Kiesewetter H, Wenzel E. Einfluß der Hämodilution auf den systemischen und den Kapillarhämatokrit. Infusionstherapie 1990; 17: 49-53.
35. Wako Y, Suzuki K, Goto Y, Kimura S. Vitamin A transports in plasma of diabetic patients. Tohoku J Exp Med 1986; 149: 133-143.
36. Basu TK, Tze WJ, Leichter J. Serum vitamin A and retinol-binding protein in patients with insulin dependent diabetes mellitus. Am J Clin Nutr 1989; 50: 329-331.
37. Gerlach TH, Zile MH. Upregulation of serum retinol in experimental acute renal failure. FASEB J 1990; 4: 2511-517.
38. Gerlach TH, Zile MH. Effect of retinoic acid and apo-RBP on serum retinol concentration in acute renal failure. FASEB J 1991; 5: 86-91.
39. Urano S, Hoshi-Hashizume M, Tochigi N, Matsuo M, Shiraki M, Ito H. Vitamin E and the susceptibility of erythrocytes and reconstituted liposomes to oxidative stress in aged diabetics. Lipids 1991; 26: 58-61.
40. Martinoli L, Di Felice M, Seghieri G, Ciuti M, De Giorgio LA, Fazzini A, et al. Plasma retinol and α-tocopherol concentrations in insulin-dependent diabetes mellitus: Their relationship to microvascular complications. Internat J Vit Nutr Res 1993; 63: 87-93.
41. Vandewoude MG, Van Gal LF, Vandewoude MF, De Leeuw IH. Vitamin E status in normocholesteremic and hyper-cholesteremic diabetic patients. Acta Diabetol Lat 1987; 24: 133-139.